{
  "id": 4551238,
  "title": "Curbing appetite: Weight loss pill available in German pharmacies - An overview",
  "url": "https://urgent.news/2026/08/31/zugelt-den-appetit-abnehmtablette-kommt-in-deutsche-apotheken-ein",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T02:00:21.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/technik/forschung-innovation/zuegelt-den-appetit-abnehmtablette-kommt-in-deutsche-apotheken-ein-ueberblick/100250684.html"
  },
  "original_language": "de",
  "account": "Novo Nordisk's Wegovy, a weight loss medication containing semaglutide, will be available in tablet form in Germany from September 1. The tablets, approved by the European Union in July, are for people with obesity or overweight and at least one weight-related condition, and require a prescription. Patients will have to pay for the treatment themselves, as it is considered a lifestyle medication, not covered by health insurance. The tablets work similarly to the injectable version, signaling to the brain that one has eaten, leading to a feeling of fullness, and are expected to have comparable effects on weight loss.",
  "summary": "The weight loss injection has been available in Germany for some time. From September, such a medication will also be available in the form of tablets. This is what you need to know.",
  "key_points": [
    "Wegovy, also Semaglutid, available in German pharmacies from September 1st",
    "Tablet form requires taking on empty stomach each morning, higher dosage than injectable"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}